603939.SS
603939.SS
CNE100001TS5
YIFENG PHARMACY CHAIN CO LTD
Loading chart...

Company Profile

Yifeng Pharmacy Chain Co., Ltd. engages in the retail business of pharmaceutical products in China. The company operates through Retail business and Wholesale business segments. The company offers Western and Chinese patent medicine, traditional Chinese medicine herbal pieces, medical devices and equipment, health supplements and products, personal care products, drugs, and convenience products related to health. It is also involved in chronic disease management, medical project investment, and medical technology development, as well as operates internet hospitals and clinics. The company also offers its products through franchise distribution and e-commerce. Yifeng Pharmacy Chain Co., Ltd. was founded in 2001 and is headquartered in Changsha, China.

Related stocks

603233.SS
603233.SS • China
DASHENLIN PHARMACEUTICAL GROUP
18.76 CNY
3.2B USD 1Y +12.9%
603883.SS
603883.SS • China
LBX PHARMACY CHAIN JOINT STOCK
13.53 CNY
1.54B USD 1Y -18.1%
3391.T
3391.T • Japan
TSURUHA HOLDINGS INC
2,123.5 JPY
6.09B USD 1Y -13.5%
7649.T
7649.T • Japan
SUGI HOLDINGS CO.LTD.
1,227.5 JPY
2.89B USD 1Y -27.4%
3349.T
3349.T • Japan
COSMOS PHARMACEUTICAL CORP
6,392 JPY
3.2B USD 1Y -23.8%
9989.T
9989.T • Japan
SUNDRUG CO LTD
3,530 JPY
2.61B USD 1Y -16.5%
3549.T
3549.T • Japan
KUSURI NO AOKI HOLDINGS CO LTD
4,138 JPY
2.48B USD 1Y +12%
002727.SZ
002727.SZ • China
YIXINTANG
10.99 CNY
963.01M USD 1Y -20.9%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
38.2% p.a.
Max Drawdown (5Y)
-64.9%
Sharpe Ratio (5Y)
-0.30
Beta Factor
0.26
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (38.2% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -70.2% in the extended horizon.
ende